Clinical Trials for Uterine Cervical Cancer

Immune PET and Proteomics for the Assessment of Response to Spatially Fractionated or Palliative Radiotherapy With or Without Immunotherapy

NCT ID: NCT06976021

This clinical trial is studying new ways to measure how well certain cancer treatments work, specifically for patients with advanced cancers like triple negative breast cancer, cervical cancer, mel...

Clinical Triage and Treatment of Atypical Glandular Cells (AGC) Detected in Screening

NCT ID: NCT05231993

Evaluation of First-void Urine as an Alternative to Cervical Sampling for Human Papillomavirus (HPV) Testing in Cervical Cancer Screening (Single-center Study).

NCT ID: NCT06254846

This clinical trial is looking at a new way to test for the Human Papillomavirus (HPV), which is linked to almost all cases of cervical cancer. The study is exploring whether using a sample of firs...

Dynamic ctDNA Assessment in Cervical and Anal Canal Tumors: Optimizing Follow-up and Clinical Outcomes

NCT ID: NCT06640283

This clinical trial is studying a new way to monitor patients with HPV-related cervical and anal cancers after they receive radiation treatment. The trial aims to use a test that looks for circulat...

A Multicenter Randomized Controlled Study of Photoelectric Detection in Cervical Cancer Screening

NCT ID: NCT06491888

This clinical trial is studying a new device that uses light to help detect cervical cancer and other cervical problems more accurately during screening. The goal is to see how well this light-base...

A Multicenter Real-world Study of Screening of Cervical Cancer Based on Photoelectric Detection

NCT ID: NCT06481930

This clinical trial is looking at a new way to detect cervical cancer using a special device that captures images of the cervix by detecting fluorescent light. The main goal is to see how accurate ...

Cadonilimab Plus Nab -Paclitaxel for Patients With Recurrent, or Metastatic Cervical Cancer Resistant to Immune Checkpoint Inhibitors

NCT ID: NCT05824494

This clinical trial is studying a new treatment approach for women with recurrent or metastatic cervical cancer that has not responded to previous immune therapies. The treatment being tested combi...